{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:13Z","timestamp":1759334653527,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jfo.2009.10.002","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T04:27:50Z","timestamp":1256876870000},"page":"679-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Occlusions veineuses r\u00e9tiniennes\u00a0: traitements anti-VEGF"],"prefix":"10.1016","volume":"32","author":[{"given":"S.","family":"Nghiem-Buffet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-Y.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2009.10.002_bib1","doi-asserted-by":"crossref","unstructured":"The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch retinal occlusion. Am J Ophthalmol 1984; 98:271-82.","DOI":"10.1016\/0002-9394(84)90316-7"},{"key":"10.1016\/j.jfo.2009.10.002_bib2","doi-asserted-by":"crossref","unstructured":"The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central retinal vein occlusion: the Central Vein Occlusion Sudy Group M Report. Ophthalmology 1995; 102:1425-33.","DOI":"10.1016\/S0161-6420(95)30849-4"},{"key":"10.1016\/j.jfo.2009.10.002_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/01.iae.0000237111.82357.30","article-title":"One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion","volume":"26","author":"Gregori","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2009.10.002_bib5","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/archopht.120.12.1644","article-title":"Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion","volume":"120","author":"Boyd","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","article-title":"Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6","volume":"140","author":"Noma","year":"2005","journal-title":"Am J Ophthalmology"},{"key":"10.1016\/j.jfo.2009.10.002_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","article-title":"Vascular endothelial growth factor upregulation in human central retinal vein occlusion","volume":"105","author":"Pe\u2019er","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2009.10.002_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0002-9394(01)01381-2","article-title":"Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate","volume":"133","author":"Tolentino","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.jfo.2009.10.002_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal Bevacizumab (avastin) treatment of macular edema in central retinal vein occlusion: a short-term study","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00417-007-0569-6","article-title":"Bevacizumab in retinal vein occlusion-results of a prospective case series","volume":"245","author":"Stahl","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IAE.0b013e31802eff83","article-title":"Intravitreal Bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study","volume":"27","author":"Costa","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/IAE.0b013e3180ed458d","article-title":"Intravitreal Bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial","volume":"27","author":"Priglinger","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2008-1027258","article-title":"Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin): preliminary results","volume":"225","author":"Pournaras","year":"2008","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.jfo.2009.10.002_bib15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/IAE.0b013e318050ca7c","article-title":"Intravitreal Bevacizumab (avastin) in central retinal vein occlusion","volume":"27","author":"Hsu","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/IAE.0b013e31804a7af2","article-title":"Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease","volume":"27","author":"Matsumoto","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0b013e3282fb7fb0","article-title":"The treatment of branch retinal vein occlusion with bevacizumab","volume":"192","author":"Badala","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/bjo.2007.123513","article-title":"Intravitreal bevacizumab for the treatment of macular edema secondary to branch retinal vein occlusion","volume":"92","author":"Kreutzer","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IAE.0b013e318030e77e","article-title":"(Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion","volume":"27","author":"Rabena","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/IAE.0b013e318188501f","article-title":"Long-term safety anf efficacy of intravitreal bevacizumab (avastin) for the managment of central retinal vein occlusion","volume":"28","author":"Gregori","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajo.2007.07.038","article-title":"Early bevacizumab treatment of central retinal vein occlusion","volume":"144","author":"Ferrara","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10792-008-9237-z","article-title":"Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection","volume":"29","author":"Alkuraya","year":"2009","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2006.12.037","article-title":"Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion","volume":"143","author":"Pai","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10633-007-9110-9","article-title":"Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study","volume":"116","author":"Moschos","year":"2008","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.eye.6702903","article-title":"Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment alone","volume":"21","author":"Ekdawi","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2009.10.002_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00347-007-1509-x","article-title":"Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion","volume":"104","author":"Schaal","year":"2007","journal-title":"Ophthalmologe"},{"issue":"8","key":"10.1016\/j.jfo.2009.10.002_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2415-8-18","article-title":"Treatment of branch retinal vein occlusion induced macular edema with bevacizumab","volume":"29","author":"Abegg","year":"2008","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/IAE.0b013e3181619bee","volume":"28","author":"Wu","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.002_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ophtha.2008.06.021","article-title":"Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions","volume":"115","author":"Pieramici","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2009.10.002_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajo.2008.08.016","article-title":"Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion","volume":"147","author":"Spaide","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1600-0420.2006.00740.x","article-title":"Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion","volume":"84","author":"Spandau","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2009.10.002_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0420.2006.00850.x","article-title":"Intravitreal bevacizumab for branch retinal vein occlusion","volume":"85","author":"Spandau","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2009.10.002_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/sj.eye.6703040","article-title":"Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion","volume":"22","author":"G\u00fcnd\u00fcz","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2009.10.002_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/jop.2007.0012","article-title":"Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema","volume":"23","author":"Byeon","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2009.10.002_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10633-007-9090-9","article-title":"Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema","volume":"116","author":"Shetty","year":"2008","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.002_bib36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bjo.2007.127282","article-title":"Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study","volume":"92","author":"Kriechbaum","year":"2008","journal-title":"Br J Ophthalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209003179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209003179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:00:38Z","timestamp":1759258838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551209003179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0181551209003179"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2009.10.002","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occlusions veineuses r\u00e9tiniennes\u00a0: traitements anti-VEGF","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2009.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}